MGAT4B and melanoma: Subsequently, by analyzing two distinct datasets that categorized melanoma patients into metastatic and primary stages, we observed a significant increase in MGAT4B expression in metastatic patients compared to those at the primary stage (SI Appendix, Fig. S8A), suggesting that MGAT4B may mediate aggressive disease in melanoma.